| scholarly article | Q13442814 |
| P2093 | author name string | Carlos Rojas-Fernandez | |
| Mina Mikhail | |||
| P2860 | cites work | Antidepressants for depressed elderly | Q24244664 |
| The PHQ-9: validity of a brief depression severity measure | Q24550620 | ||
| Venlafaxine extended-release: a review of its use in the management of major depression | Q28214486 | ||
| A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, and fluoxetine in treatment-resistant major depressive disorder | Q28291261 | ||
| Development and validation of a geriatric depression screening scale: a preliminary report | Q29615638 | ||
| Updating the Beers Criteria for Potentially Inappropriate Medication Use in Older Adults | Q30050268 | ||
| Effects of venlafaxine on blood pressure: a meta-analysis of original data from 3744 depressed patients | Q31974256 | ||
| The effect of a primary care practice-based depression intervention on mortality in older adults: a randomized trial | Q33638700 | ||
| Epidemiology and diagnosis of depression in late life | Q33747861 | ||
| SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression | Q33884433 | ||
| SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants | Q33989845 | ||
| Medication augmentation after the failure of SSRIs for depression. | Q33994373 | ||
| The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled study. | Q34004814 | ||
| Selective serotonin reuptake inhibitors and cytochrome P-450 mediated drug-drug interactions: an update | Q34116936 | ||
| Combining antidepressants for treatment-resistant depression: a review | Q34146187 | ||
| Clinical pharmacology of MAO inhibitors: safety and future | Q34286633 | ||
| Clinical guidelines for the treatment of depressive disorders. V. Combining psychotherapy and pharmacotherapy. | Q34301074 | ||
| Augmentation and combination strategies in treatment-resistant depression. | Q34383678 | ||
| Treatment of dysthymia and minor depression in primary care: A randomized controlled trial in older adults. | Q51973773 | ||
| Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized controlled trial in patients older than 59 years. | Q51988085 | ||
| Recovery and relapse from major depressive disorder in the elderly | Q52040948 | ||
| The temporal relationship between depressive symptoms and dementia: a community-based prospective study. | Q53333980 | ||
| The Serotonin Syndrome | Q55871784 | ||
| Combining Antidepressants for Treatment-Resistant Depression | Q56038603 | ||
| Vascular Disease, Depression, and Dementia | Q58391646 | ||
| The course of geriatric depression with "reversible dementia": a controlled study | Q58391689 | ||
| Suboptimal use of antidepressants in the elderly: a population-based study in Nova Scotia | Q73980523 | ||
| The efficacy, safety and tolerability of antidepressants in late life depression: a meta-analysis | Q74453942 | ||
| Clinical presentation of the "depression-executive dysfunction syndrome" of late life | Q77487060 | ||
| STAR*D: what have we learned? | Q79700849 | ||
| Maintenance treatment of major depression in old age | Q82843539 | ||
| What is the optimal duration of a short-term antidepressant trial when treating geriatric depression? | Q83190492 | ||
| Depression in the elderly | Q34423873 | ||
| An open-label, rater-blinded, augmentation study of aripiprazole in treatment-resistant depression | Q34642676 | ||
| Monoamine oxidase inhibitors: a modern guide to an unrequited class of antidepressants | Q34867111 | ||
| Comorbidity of late life depression: an opportunity for research on mechanisms and treatment | Q34934354 | ||
| Atypical antipsychotic augmentation in major depressive disorder: a meta-analysis of placebo-controlled randomized trials | Q34997918 | ||
| Managing treatment-resistant major depression. | Q35081154 | ||
| Depression and Bipolar Support Alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in late life | Q35177802 | ||
| Depression, mortality, and medical morbidity in patients with coronary heart disease | Q35189639 | ||
| Poststroke depression: prevalence, diagnosis, treatment, and disease progression | Q35189676 | ||
| Population projection of US adults with lifetime experience of depressive disorder by age and sex from year 2005 to 2050. | Q35516461 | ||
| Late-life depression: a model for medical classification. | Q36199216 | ||
| Achieving adequate outcomes in geriatric depression: standardized criteria for remission | Q36199617 | ||
| Aging-related diagnostic variations: need for diagnostic criteria appropriate for elderly psychiatric patients | Q36231089 | ||
| Vascular depression: An archetypal neuropsychiatric disorder | Q36677910 | ||
| Getting better, getting well: understanding and managing partial and non-response to pharmacological treatment of non-psychotic major depression in old age. | Q36951926 | ||
| Clinical practice. Late-life depression | Q37018424 | ||
| Strategies for switching antidepressants to achieve maximum efficacy adolescents | Q37169613 | ||
| Tolerability of selective serotonin reuptake inhibitors: issues relevant to the elderly | Q37186658 | ||
| Use of antidepressants in late-life depression | Q37275966 | ||
| Nonresponse, partial response, and failure to achieve remission: humanistic and cost burden in major depressive disorder | Q37285959 | ||
| A systematic review of augmentation strategies for patients with major depressive disorder. | Q37596947 | ||
| Extended-release quetiapine as adjunct to an antidepressant in patients with major depressive disorder: results of a randomized, placebo-controlled, double-blind study. | Q38382524 | ||
| Suboptimal antidepressant use in the elderly | Q38475014 | ||
| Aripiprazole augmentation in major depressive disorder: a double-blind, placebo-controlled study in patients with inadequate response to antidepressants | Q39304379 | ||
| Predictors of antidepressant use among older adults: have they changed over time? | Q40434218 | ||
| Use of antidepressants among elderly subjects: trends and contributing factors | Q40775699 | ||
| The diagnosis and treatment of late-life depression | Q40997056 | ||
| Diagnosis and treatment of depression in late life. Consensus statement update | Q41608678 | ||
| Aripiprazole augmentation of antidepressants for the treatment of partially responding and nonresponding patients with major depressive disorder | Q42672198 | ||
| Aripiprazole augmentation of selective serotonin reuptake inhibitors for treatment-resistant major depressive disorder | Q42672211 | ||
| A novel augmentation strategy for treating resistant major depression | Q43514882 | ||
| Depression and service utilization in elderly primary care patients | Q44088918 | ||
| The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study | Q44627462 | ||
| A comparison of side effects of selective serotonin reuptake inhibitors and tricyclic antidepressants in older depressed patients: a meta-analysis | Q45004704 | ||
| STAR*D: revising conventional wisdom. | Q45931500 | ||
| Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation | Q46062036 | ||
| Treatment of residual anxiety symptoms with adjunctive aripiprazole in depressed patients taking selective serotonin reuptake inhibitors | Q46429561 | ||
| Sequenced Treatment Alternatives to Relieve Depression (STAR*D): lessons learned. | Q46440703 | ||
| Late-onset major depression: clinical and treatment-response variability | Q46602365 | ||
| MRI-defined vascular depression | Q48753769 | ||
| Differential pharmacology of newer antidepressants. | Q48774817 | ||
| Pharmacists' role in depression care: a survey of attitudes, current practices, and barriers. | Q51878149 | ||
| P433 | issue | 3 | |
| P921 | main subject | pharmacotherapy | Q701216 |
| P304 | page(s) | 128-135.e2 | |
| P577 | publication date | 2012-05-01 | |
| P1433 | published in | Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC | Q26853782 |
| P1476 | title | Contemporary concepts in the pharmacotherapy of depression in older people | |
| P478 | volume | 145 |
Search more.